LR-108

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLR-108
Drug Alias NameLR-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D agonists
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBone Care International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBone Care International Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A